Close
ACHEMA MIDDLE EAST 2026

GSK welcomes launch of the UK Government’s Life Sciences Sector Deal

GSK welcomes the launch of the UK Government’s Life Sciences Sector Deal, which builds on the Industrial Strategy published by Sir John Bell earlier...

Canon BioMedical products now available in Austria, Germany, and Switzerland

Canon BioMedical is pleased to announce our latest geographic expansion into the German-speaking countries of Austria, Germany, and Switzerland. We are working with a...

Sanofi’s BRIGHT study comparing Toujeo with insulin degludec meets primary objective

Sanofi's Toujeo met the primary study objective in the first large head-to-head clinical trial, called BRIGHT study, comparing Toujeo with insulin degludec. Sanofi plans...

EMA accepts marketing application for trastuzumab and pegfilgrastim

The European Medicines Agency (EMA) has accepted to review Mylan’s marketing authorisation applications (MAA) for proposed biosimilar trastuzumab and proposed biosimilar pegfilgrastim. The proposed biosimilars...

Merck to present new and updated data of Keytruda to treat breast cancers at 2017 SABC symposium

Merck, known as MSD outside the United States and Canada, announced that new and updated data from six abstracts investigating Keytruda (pembrolizumab), the company’s...

Sanofi Expects $120 Million Hit As Dengue Vaccine Hits Major Snag

Use of Sanofi’s dengue vaccine, the world’s first approved shot against the mosquito-borne virus, is to be strictly limited due to evidence it can...

The European Medicines Agency accepts regulatory submission for Tagrisso in 1st-line EGFR-mutated non-small cell lung cancer

AstraZeneca today announced that the EMA has accepted a variation to the Marketing Authorisation Application (MAAv) for Tagrisso (osimertinib), a third-generation, irreversible epidermal growth...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...